ID   WMM1215
AC   CVCL_W754
DR   cancercelllines; CVCL_W754
DR   Cosmic; 929201
DR   Wikidata; Q54994351
RX   PubMed=10338330;
RX   PubMed=23455323;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23455323).
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Asp842Val (c.2525A>T); ClinVar=VCV000013543; Zygosity=Unspecified (PubMed=23455323).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 8
//
RX   PubMed=10338330; DOI=10.1097/00008390-199902000-00003;
RA   Rizos H., Darmanian A.P., Indsto J.O., Shannon J.A., Kefford R.F.,
RA   Mann G.J.;
RT   "Multiple abnormalities of the p16INK4a-pRb regulatory pathway in
RT   cultured melanoma cells.";
RL   Melanoma Res. 9:10-19(1999).
//
RX   PubMed=23455323; DOI=10.1038/onc.2013.45;
RA   Becker T.M., Boyd S.C., Mijatov B., Gowrishankar K., Snoyman S.,
RA   Pupo G.M., Scolyer R.A., Mann G.J., Kefford R.F., Zhang X.-D.,
RA   Rizos H.;
RT   "Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3
RT   transcription factor.";
RL   Oncogene 33:1158-1166(2014).
//